Janus Henderson Group plc 13D and 13G filings for Bellerophon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-09 1:03 pm Sale |
2023-06-06 | 13G | Bellerophon Therapeutics, Inc. BLPH |
JANUS HENDERSON GROUP PLC JHG |
0 0.000% |
-1,263,065 (Position Closed) |
Filing |
| 2023-05-26 4:41 pm Purchase |
2023-05-23 | 13G | Bellerophon Therapeutics, Inc. BLPH |
JANUS HENDERSON GROUP PLC JHG |
1,263,065 12.100% |
726,631 (+135.46%) |
Filing |
| 2023-05-25 11:17 am Purchase |
2023-05-15 | 13G | Bellerophon Therapeutics, Inc. BLPH |
JANUS HENDERSON GROUP PLC JHG |
536,434 5.100% |
536,434 (New Position) |
Filing |